Thierry F Calandra


Ontology type: schema:Person     


Person Info

NAME

Thierry F

SURNAME

Calandra

Publications in SciGraph latest 50 shown

  • 2022-04-19 Correction: Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) in LEUKEMIA
  • 2022-04-02 Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN) in LEUKEMIA
  • 2022-02-11 High levels of monocytic myeloid-derived suppressor cells are associated with favorable outcome in patients with pneumonia and sepsis with multi-organ failure in INTENSIVE CARE MEDICINE EXPERIMENTAL
  • 2021-08-09 The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients in NATURE COMMUNICATIONS
  • 2021-06-23 Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis in INTENSIVE CARE MEDICINE
  • 2020-06-22 Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion in INTENSIVE CARE MEDICINE
  • 2020-03-18 Risk factors for candidemia: a prospective matched case-control study in CRITICAL CARE
  • 2018-04-14 Antimicrobial Therapy in HANDBOOK OF SEPSIS
  • 2017-11-03 Low sensitivity of qSOFA, SIRS criteria and sepsis definition to identify infected patients at risk of complication in the prehospital setting and at the emergency department triage in SCANDINAVIAN JOURNAL OF TRAUMA, RESUSCITATION AND EMERGENCY MEDICINE
  • 2017-03-02 Intensive care medicine research agenda on invasive fungal infection in critically ill patients in INTENSIVE CARE MEDICINE
  • 2017-02-15 Role of TLR1, TLR2 and TLR6 in the modulation of intestinal inflammation and Candida albicans elimination in GUT PATHOGENS
  • 2016-05-27 Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy in CRITICAL CARE
  • 2016-05-17 Advances in antibiotic therapy in the critically ill in CRITICAL CARE
  • 2016-01-27 Novel strategies for targeting innate immune responses to influenza in MUCOSAL IMMUNOLOGY
  • 2014-10-30 A revival for immunoglobulin therapy in septic shock? in INTENSIVE CARE MEDICINE
  • 2014-08-05 Resistance of Candida spp. to antifungal drugs in the ICU: where are we now? in INTENSIVE CARE MEDICINE
  • 2013-12-18 What’s new in antimicrobial use and resistance in critically ill patients? in INTENSIVE CARE MEDICINE
  • 2012-09-13 Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C in RETROVIROLOGY
  • 2012-07-02 Pancreatic stone protein as an early biomarker predicting mortality in a prospective cohort of patients with sepsis requiring ICU management in CRITICAL CARE
  • 2011-02-20 Dominant TNF-α+Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease in NATURE MEDICINE
  • 2010-12-08 The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia in CRITICAL CARE
  • 2010-06 Interleukin-33 safeguards neutrophils in sepsis in NATURE MEDICINE
  • 2010-02-23 Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors in MOLECULAR PSYCHIATRY
  • 2009-01-27 Caspofungin for prevention of intra-abdominal candidiasis in high-risk surgical patients in INTENSIVE CARE MEDICINE
  • 2008-11-18 Fully human anti-macrophage migration inhibitory factor antibodies as potential therapeutics for sepsis and septic shock in CRITICAL CARE
  • 2008-02-29 Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 in INTENSIVE CARE MEDICINE
  • 2008-01-22 Bench-to-bedside review: Candida infections in the intensive care unit in CRITICAL CARE
  • 2007-12-04 Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 in INTENSIVE CARE MEDICINE
  • 2007-09-26 A functional microsatellite in the macrophage migration inhibitory factor gene influences susceptibility to meningococcal sepsis in CRITICAL CARE
  • 2007-01-01 Early-Onset Pro-inflammatory Cytokines in MECHANISMS OF SEPSIS-INDUCED ORGAN DYSFUNCTION AND RECOVERY
  • 2006-08-01 In vitro antimicrobial activity of moxifloxacin against bacterial strains isolated from blood of neutropenic cancer patients in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2006-01-20 Bloodstream and endovascular infections due to Abiotrophia defectiva and Granulicatellaspecies in BMC INFECTIOUS DISEASES
  • 2005-12-07 Coxiella burnetii vascular graft infection in BMC INFECTIOUS DISEASES
  • 2005-09-20 Invasive candidiasis: comparison of management choices by infectious disease and critical care specialists in INTENSIVE CARE MEDICINE
  • 2004-03-03 Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock in INTENSIVE CARE MEDICINE
  • 2004-01-15 Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients with Community-Acquired Pneumonia in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2003-10 Macrophage migration inhibitory factor: a regulator of innate immunity in NATURE REVIEWS IMMUNOLOGY
  • 2003-06-13 Response to van Saene et al.'s comment on "Prevention of severe Candida infections in non-neutropenic, high-risk, critically ill patients" in INTENSIVE CARE MEDICINE
  • 2003-03-03 Anticytokine Therapies in Patients with Severe Sepsis and Septic Shock in CYTOKINES AND CHEMOKINES IN INFECTIOUS DISEASES HANDBOOK
  • 2002-12 Antifungal prophylaxis for intensive care unit patients: let's fine tune it in INTENSIVE CARE MEDICINE
  • 2002 Inhibitory Cytokines in IMMUNE RESPONSE IN THE CRITICALLY ILL
  • 2002-01-01 Empirical Antibiotic Therapy for Patients with Severe Sepsis and Septic Shock in THE SEPSIS TEXT
  • 2001-12 MIF regulates innate immune responses through modulation of Toll-like receptor 4 in NATURE
  • 2001-03-02 Breakthrough Streptococcus pneumoniae Meningitis During Clarithromycin Therapy for Acute Otitis Media in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2001-03 Breakthrough Streptococcus pneumoniae Meningitis During Clarithromycin Therapy for Acute Otitis Media in EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
  • 2001-02 Antibiotics in sepsis in INTENSIVE CARE MEDICINE
  • 2001 Macrophage Migration Inhibitory Factor (MIF): A Pro-Inflammatory Mediator of Sepsis in EVOLVING CONCEPTS IN SEPSIS AND SEPTIC SHOCK
  • 2000-11 Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 in NATURE
  • 2000-02-01 Protection from septic shock by neutralization of macrophage migration inhibitory factor in NATURE MEDICINE
  • 1999-02 Treatment of Sepsis in DRUGS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "http://www.grid.ac/institutes/grid.9851.5", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414601.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.8515.9", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414363.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.4367.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10417.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.240382.f", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.428469.5", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.412966.e", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.414250.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7445.2", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.250903.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.40263.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.435069.d", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.418119.4", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.64212.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.415502.7", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.7634.6", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.10253.35", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "http://www.grid.ac/institutes/grid.411896.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Calandra", 
        "givenName": "Thierry F", 
        "id": "sg:person.01103701061.44", 
        "identifier": [
          {
            "name": "orcid_id", 
            "type": "PropertyValue", 
            "value": "0000-0003-3051-1285"
          }
        ], 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44", 
          "https://orcid.org/0000-0003-3051-1285"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2022-08-04T17:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/person/person_725.jsonl", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01103701061.44'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01103701061.44'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01103701061.44'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01103701061.44'


     

    This table displays all metadata directly associated to this object as RDF triples.

    61 TRIPLES      11 PREDICATES      33 URIs      8 LITERALS      3 BLANK NODES

    Subject Predicate Object
    1 sg:person.01103701061.44 schema:affiliation Nbd0973c8094c4fe8bb78b09ae11b4613
    2 grid-institutes:grid.10253.35
    3 grid-institutes:grid.10417.33
    4 grid-institutes:grid.17063.33
    5 grid-institutes:grid.240382.f
    6 grid-institutes:grid.250903.d
    7 grid-institutes:grid.40263.33
    8 grid-institutes:grid.411896.3
    9 grid-institutes:grid.412966.e
    10 grid-institutes:grid.414250.6
    11 grid-institutes:grid.414363.7
    12 grid-institutes:grid.414601.6
    13 grid-institutes:grid.415502.7
    14 grid-institutes:grid.418119.4
    15 grid-institutes:grid.428469.5
    16 grid-institutes:grid.435069.d
    17 grid-institutes:grid.4367.6
    18 grid-institutes:grid.64212.33
    19 grid-institutes:grid.7445.2
    20 grid-institutes:grid.7634.6
    21 grid-institutes:grid.8515.9
    22 schema:familyName Calandra
    23 schema:givenName Thierry F
    24 schema:identifier N68273314915a47ccb15516b5729e2e74
    25 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01103701061.44
    26 https://orcid.org/0000-0003-3051-1285
    27 schema:sdDatePublished 2022-08-04T17:38
    28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    29 schema:sdPublisher Na4962c2d90a940ddb60e6c18834d0c68
    30 sgo:license sg:explorer/license/
    31 sgo:sdDataset persons
    32 rdf:type schema:Person
    33 N68273314915a47ccb15516b5729e2e74 schema:name orcid_id
    34 schema:value 0000-0003-3051-1285
    35 rdf:type schema:PropertyValue
    36 Na4962c2d90a940ddb60e6c18834d0c68 schema:name Springer Nature - SN SciGraph project
    37 rdf:type schema:Organization
    38 Nbd0973c8094c4fe8bb78b09ae11b4613 schema:affiliation grid-institutes:grid.9851.5
    39 sgo:isCurrent true
    40 rdf:type schema:OrganizationRole
    41 grid-institutes:grid.10253.35 schema:Organization
    42 grid-institutes:grid.10417.33 schema:Organization
    43 grid-institutes:grid.17063.33 schema:Organization
    44 grid-institutes:grid.240382.f schema:Organization
    45 grid-institutes:grid.250903.d schema:Organization
    46 grid-institutes:grid.40263.33 schema:Organization
    47 grid-institutes:grid.411896.3 schema:Organization
    48 grid-institutes:grid.412966.e schema:Organization
    49 grid-institutes:grid.414250.6 schema:Organization
    50 grid-institutes:grid.414363.7 schema:Organization
    51 grid-institutes:grid.414601.6 schema:Organization
    52 grid-institutes:grid.415502.7 schema:Organization
    53 grid-institutes:grid.418119.4 schema:Organization
    54 grid-institutes:grid.428469.5 schema:Organization
    55 grid-institutes:grid.435069.d schema:Organization
    56 grid-institutes:grid.4367.6 schema:Organization
    57 grid-institutes:grid.64212.33 schema:Organization
    58 grid-institutes:grid.7445.2 schema:Organization
    59 grid-institutes:grid.7634.6 schema:Organization
    60 grid-institutes:grid.8515.9 schema:Organization
    61 grid-institutes:grid.9851.5 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...